US drafting plans to allow sale of some unapproved peptides, Washington Post reports
The report points to a federal opening for products that currently sit outside the approval pathway and are sold through gray-market channels.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 7 20:43 ETSource: TradingView
The wire
- 01The Washington Post reports that the US government is drafting plans that would permit the sale of certain unapproved peptides, according to coverage of the story.
- 02Any such pathway would directly affect compounders, telehealth prescribers and clinics now operating around FDA category lists and import rules for research peptides.
- 03No agency text, scope or timeline has been published; readers should treat the plans as reported drafts until an official notice or rule appears.
From the source
Read at tradingview.comUS is drafting plans for sale of some unapproved peptides, the Washington Post reports
